Topic Editors

School of Applied Sciences, University of the West of England, Bristol, UK
1. Department of Nutrition and Public Health, University of Agder, Universitetsveien 25, 4604 Kristiansand, Norway
2. Faculty of Health Sciences, University of Pécs, Vörösmarty M. Str. 4, H-7621 Pécs, Hungary
1. School of Health and Life Sciences, University of Health and Rehabilitation Sciences, Qingdao 266071, China
2. School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China
Department of Stress, Development and Signaling of Plants, Plant Reproductive Biology and Advanced Microscopy Laboratory (BReMAP), Estación Experimental del Zaidín, CSIC, 18008 Granada, Spain

Cell Signaling and Redox Biology: From Molecular Mechanisms to Therapeutic Applications

Abstract submission deadline
30 September 2026
Manuscript submission deadline
31 December 2026
Viewed by
1878

Topic Information

Dear Colleagues,

Cell signaling events and pathways control a cell’s environmental perception and subsequent functioning. It is now apparent that redox biology is part of the suite of mechanisms which orchestrate signaling events in cells. Internally, the redox status of a cell is held at a reducing level and is finely controlled in a balanced manner. This is achieved by the presence of many small redox-active molecules, such as glutathione and ascorbate, but also by a number of dietary antioxidants, such as vitamin E, and by antioxidant enzymes such as superoxide dismutase and catalase. Numerous small reactive molecules can be generated, and their metabolism can maintain or disrupt the redox balance of cells. These include reactive oxygen species (ROS), such as hydrogen peroxide (H2O2), reactive nitrogen species (RNS), such as nitric oxide (NO), and reactive sulfur species (RSS), such as hydrogen sulfide (H2S). Redox mechanisms can control the action of proteins through covalent modifications, for example, by S-nitrosylation, therefore controlling cellular activities. Cell growth, development, and death, for example, through apoptosis, can all be controlled, in part, by redox metabolism. Redox dysfunction has been associated with a range of stress responses and diseases, both in plants and animals. Redox events can be used in pathogen control, as well as cellular dysfunction, through nitro-oxidative stress. Diseases such as Parkinson’s, Alzheimer’s, and other neurodegenerative diseases often have an element of redox imbalance, as does diabetes. The aging process also involves redox metabolism. Therefore, an understanding of the molecular mechanisms of redox biology and how therapeutics and treatments can be used to manipulate cellular redox is important. This Topic aims to bring together an array of cutting-edge research articles on redox biology from a range of organisms, from plants and nematodes to humans. Papers may be primary research articles or reviews. Interdisciplinary research is particularly welcomed, as are opinion articles suggesting ways to navigate bottlenecks in the field.

Prof. Dr. John T. Hancock
Prof. Dr. Sergej M. Ostojic
Prof. Dr. Jiankang Liu
Dr. Juan de Dios Alché Ramírez
Topic Editors

Keywords

  • aging
  • agricultural treatments
  • antioxidants
  • antioxidant enzymes
  • chloroplasts
  • diabetes
  • gene expression
  • glutathione
  • hydrogen gas
  • mitochondria
  • neurodegenerative disease
  • pathogen challenge
  • peroxisomes
  • protein modifications
  • reactive nitrogen species (RNS)
  • reactive oxygen species (ROS)
  • reactive sulfur species (RSS)
  • redox metabolism
  • senescence
  • stress responses
  • systemic responses
  • therapies and therapeutics

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Antioxidants
antioxidants
6.6 12.4 2012 18.7 Days CHF 2900 Submit
Biology
biology
3.5 7.4 2012 16.8 Days CHF 2700 Submit
Nitrogen
nitrogen
2.3 2.8 2020 16.7 Days CHF 1200 Submit
Oxygen
oxygen
- 8.4 2021 26.7 Days CHF 1200 Submit
Clinical Bioenergetics
clinbioenerg
- - 2025 15.0 days * CHF 1000 Submit
Plants
plants
4.1 7.6 2012 16.5 Days CHF 2700 Submit
Biomedicines
biomedicines
3.9 6.8 2013 21 Days CHF 2600 Submit

* Median value for all MDPI journals in the second half of 2025.


Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers (3 papers)

Order results
Result details
Journals
Select all
Export citation of selected articles as:
22 pages, 1390 KB  
Review
Ferroptosis in Myocardial Fibrosis: Mechanisms and Therapeutic Insights
by Xuefeng Lin, Weijun Li, Jiahao Ye and Lin Li
Antioxidants 2026, 15(1), 70; https://doi.org/10.3390/antiox15010070 - 6 Jan 2026
Viewed by 543
Abstract
Myocardial fibrosis (MF) is a common pathological feature of diverse cardiac disorders and is a key driving factor of cardiac dysfunction. It is marked by excessive deposition of extracellular matrix (ECM) proteins, particularly collagen type I and III, and a prolonged activation of [...] Read more.
Myocardial fibrosis (MF) is a common pathological feature of diverse cardiac disorders and is a key driving factor of cardiac dysfunction. It is marked by excessive deposition of extracellular matrix (ECM) proteins, particularly collagen type I and III, and a prolonged activation of cardiac fibroblasts. However, the molecular drivers of this process remain undetermined. Ferroptosis is an iron-catalyzed, lipid-peroxidation-dependent mode of regulated cell death. Research indicates that ferroptosis is significantly involved in the onset and advancement of MF; consequently, developing therapies that selectively modulate ferroptosis presents a promising direction of treatment options. Therefore, this paper systematically discusses the mechanisms associated with ferroptosis to explore the link between ferroptosis and MF from multiple dimensions, including iron metabolism disorders, lipid peroxidation, imbalance of glutathione metabolism, and the dysregulated activation of ferroptosis regulatory pathways, to provide innovative perspectives for the study of the specific molecular mechanisms and treatment of MF. Method: By retrieving the literature on the mechanism of ferroptosis in MF published in PubMed and Web of Science databases from 2020 to July 2025, the mechanism of action was systematically analyzed and reviewed. Full article
Show Figures

Figure 1

21 pages, 7425 KB  
Article
Oxidative-Stress-Mediated AMPK/mTOR Signaling in Bovine Mastitis: An Integrative Analysis Combining 16S rDNA Sequencing and Molecular Pathology
by Yuanyuan Zhang, Min Zhang, Daqing Wang, Feifei Zhao, Luofei Jia, Zhiwei Sun, Guifang Cao and Yong Zhang
Biology 2026, 15(2), 115; https://doi.org/10.3390/biology15020115 - 6 Jan 2026
Viewed by 359
Abstract
The bovine mammary gland, the exclusive site of milk synthesis, is a structurally specialized tissue that houses distinct cellular subsets, yet it remains highly susceptible to major mastitis pathogens, including Staphylococcus aureus, Streptococcus agalactiae, and Escherichia coli. Infection disrupts redox [...] Read more.
The bovine mammary gland, the exclusive site of milk synthesis, is a structurally specialized tissue that houses distinct cellular subsets, yet it remains highly susceptible to major mastitis pathogens, including Staphylococcus aureus, Streptococcus agalactiae, and Escherichia coli. Infection disrupts redox homeostasis, leading to excessive accumulation of reactive oxygen species (ROS) and rapid activation of antioxidant pathways. In this study, we integrated 16S DNA sequencing, histopathology (hematoxylin and eosin), and immunohistochemistry to map the mastitis-associated microbiota and visualize oxidative-damage foci in mammary tissues challenged by Staphylococcus aureus, Streptococcus agalactiae, or Escherichia coli. Quantitative reverse transcription polymerase chain reaction and Western blot analyses were subsequently performed on the same samples to measure the kinetic response of six oxidative-stress-related signalling nodes: adenosine 5′-monophosphate-activated protein kinase, cytochrome P450 1A1, heme oxygenase 1, nitric oxide synthase, mammalian target of rapamycin, and superoxide dismutase. By correlating the temporal expression patterns of these genes/proteins with ROS accumulation and histological severity, this study delineates the molecular cascade linking oxidative imbalance to mastitis pathology, providing data-driven targets for future preventive and therapeutic strategies. Full article
Show Figures

Figure 1

16 pages, 2307 KB  
Article
IL-1β Controls Proliferation, Apoptosis, and Necroptosis Through the PI3K/AKT/Src/NF-κB Pathway in Leukaemic Lymphoblasts
by Zitlal-Lin Victoria-Avila, Elba Reyes-Maldonado, María Lilia Domínguez-López, Jorge Vela-Ojeda, Aranza Lozada-Ruiz, Omar Rafael Alemán and Ruth Angélica Lezama
Biomedicines 2026, 14(1), 41; https://doi.org/10.3390/biomedicines14010041 - 24 Dec 2025
Viewed by 480
Abstract
Background: Chronic inflammation and the development of cancer are closely linked, with components that comprise the tumour microenvironment—including proinflammatory cytokines—exerting essential tumourigenic effects. These proinflammatory cytokines include IL-1β, which has been reported to be overexpressed in several cancers and shown to activate several [...] Read more.
Background: Chronic inflammation and the development of cancer are closely linked, with components that comprise the tumour microenvironment—including proinflammatory cytokines—exerting essential tumourigenic effects. These proinflammatory cytokines include IL-1β, which has been reported to be overexpressed in several cancers and shown to activate several signalling pathways. These pathways may involve kinases such as AKT (serine/threonine kinase) and Src (Proto-oncogene tyrosine-protein kinase), and have a broad capacity to activate nuclear factors, including NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells), which can regulate the transcription of genes encoding proteins such as cIAP1 (Cellular Inhibitor of Apoptosis Protein 1), Bcl-2 (B-cell lymphoma 2), and cyclin D1, thereby regulating processes like apoptosis and cell cycle inhibition. Objectives: The aim of this study was to investigate the role of IL-1β (Interleukin-1 beta) in regulating cell death and proliferation in RS4:11 leukaemic lymphoblasts via the PI3K (Phosphoinositide 3-kinase)/AKT/Src/NF-κB pathway using an in vitro experimental approach. Methods: We employed flow cytometry to determine the expression levels and phosphorylation status of various proteins; proliferation was assessed using the CCK-8 kit, and apoptosis was evaluated with the Annexin V kit. Results: Our findings indicate that the IL-1β-activated signalling pathway modulates these cellular processes in leukaemic lymphoblasts. Conclusions: We therefore conclude that IL-1β exerts significant effects on cell death and proliferation in leukaemic lymphoblasts through the PI3K/AKT/NF-κB pathway, with the study’s findings indicating that an inflammatory environment may promote such lymphoblasts to acquire neoplastic characteristics. As such, the proteins involved in the effects evaluated in this work could be considered as potential therapeutic targets for the treatment of Acute Lymphoblastic Leukaemia (ALL). Full article
Show Figures

Graphical abstract

Back to TopTop